Zhejiang Medicine Co., Ltd.

Shanghai Stock Exchange 600216.SS

Zhejiang Medicine Co., Ltd. Operating Income for the year ending December 31, 2023: USD 53.55 M

Zhejiang Medicine Co., Ltd. Operating Income is USD 53.55 M for the year ending December 31, 2023, a -46.28% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Zhejiang Medicine Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 99.67 M, a -46.30% change year over year.
Zhejiang Medicine Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 185.62 M, a 37.27% change year over year.
Zhejiang Medicine Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 135.22 M, a 130.21% change year over year.
Zhejiang Medicine Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 58.74 M, a -13.89% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Shanghai Stock Exchange: 600216.SS

Zhejiang Medicine Co., Ltd.

CEO	Mr. Chun Lei Lu
IPO Date	Oct. 21, 1999
Location	China
Headquarters	168 Zhiyuan Middle Avenue
Employees	6,227
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Zhejiang Medicine Co., Ltd. produces and sells life nutrition and pharmaceutical products in China. The company offers life nutrition products, such as synthetic vitamin E, vitamin A, natural vitamin E, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, lycopene, and other vitamins and vitamin products. It also provides pharmaceutical manufacturing products, including anti-drug resistant antibiotics, anti-malaria and other pharmaceutical raw materials, quinolones, and anti-drug resistant products; and pharmaceutical products comprising sugars and hormones. The company was founded in 1997 and is headquartered in Shaoxing, China.

Key trends

Past 5 years